Page 14 - ARNM-2-1
P. 14

Advances in Radiotherapy
            & Nuclear Medicine                                                 Pediatric myelosuppression in radiotherapy



               2010;37(6):1238-1250.                              Invest. 1992;10(5):349-355.
               doi: 10.1007/s00259-010-1422-4                     doi: 10.3109/07357909209024794
            4.   Hua CH, Mascia AE, Seravalli E, Lomax AJ, Seiersen K,   13.  Jefferies S, Rajan B, Ashley S, Traish D, Brada M.
               Ulin K. Advances in radiotherapy technology for pediatric   Haematological toxicity of cranio-spinal irradiation.
               cancer  patients  and  roles  of  medical  physicists:  COG   Radiother Oncol. 1998;48(1):23-27.
               and SIOP Europe perspectives.  Pediatr Blood Cancer.
               2021;68(Suppl 2):e28344.                           doi: 10.1016/s0167-8140(98)00024-3
                                                               14.  Pearce MS, Salotti JA, Little MP, et al. Radiation exposure
               doi: 10.1002/pbc.28344
                                                                  from CT scans in childhood and subsequent risk of
            5.   Bosch de Basea Gomez M, Thierry-Chef I, Harbron R, et al.   leukaemia and brain tumours: A retrospective cohort study.
               Risk of hematological malignancies from CT radiation   Lancet. 2012;380(9840):499-505.
               exposure in children, adolescents and young adults.  Nat
               Med. 2023;29:3111-3119.                            doi: 10.1016/s0140-6736(12)60815-0
                                                               15.  Constine LS, Ronckers CM, Hua CH, et al. Pediatric normal
               doi: 10.1038/s41591-023-02620-0
                                                                  tissue effects in the clinic (PENTEC): An International
            6.   Sylvester R. WHO handbook for reporting results of cancer   Collaboration to analyse normal tissue radiation dose-
               treatment: WHO offset publication #48 World Health   volume response relationships for paediatric cancer patients.
               Organization,  Geneva,  1979,  45  pages,  6  Swiss  Francs.   Clin Oncol (R Coll Radiol). 2019;31(3):199-207.
               Control Clin Trials. 1980;1(3):276-277.
                                                                  doi: 10.1016/j.clon.2019.01.002
               doi: 10.1016/0197-2456(80)90009-4
                                                               16.  Chang EL, Allen P, Wu C, Ater J, Kuttesch J, Maor MH.
            7.   Gilreath JA, Stenehjem DD, Rodgers GM. Diagnosis   Acute toxicity and treatment interruption related to electron
               and treatment of cancer-related anemia.  Am J Hematol.   and photon craniospinal irradiation in pediatric patients
               2014;89(2):203-212.                                treated at the University of Texas M. D. Anderson Cancer
               doi: 10.1002/ajh.23628                             Center. Int J Radiat Oncol Biol Phys. 2002;52(4):1008-1016.
            8.   Cristy M. Active bone marrow distribution as a function of      doi: 10.1016/s0360-3016(01)02717-1
               age in humans. Phys Med Biol. 1981;26(3):389-400.  17.  Kumar N, Miriyala R, Thakur P,  et al. Impact of acute
               doi: 10.1088/0031-9155/26/3/003                    hematological toxicity on treatment interruptions during
                                                                  cranio-spinal irradiation in medulloblastoma: A  tertiary
            9.   Liu H, Wang J, Huang Y, et al. Development and validation   care institute experience. J Neurooncol. 2017;134(2):309-315.
               of a Web-crawler-based medical records information
               aggregation tool. Chin J Med Phys. 2021;11(5):1444-1448.     doi: 10.1007/s11060-017-2524-7
               doi: 10.3969/j.issn.1005-202X.2021.11.022       18.  Zhang Y, Yan Y, Nath R, Bao S, Deng J. Personalized
                                                                  estimation of dose to red bone marrow and the associated
            10.  Harari  PM, Harris  J, Kies  MS,  et al. Postoperative   leukaemia risk attributable to pelvic kilo-voltage cone beam
               chemoradiotherapy  and  cetuximab  for  high-risk  computed tomography scans in image-guided radiotherapy.
               squamous cell carcinoma of the head and neck: Radiation   Phys Med Biol. 2012;57(14):4599-4612.
               Therapy Oncology Group  RTOG-0234.  J  Clin Oncol.
               2014;32(23):2486-2495.                             doi: 10.1088/0031-9155/57/14/4599
               doi: 10.1200/jco.2013.53.9163                   19.  Wang Y, Wang H, Zheng A, et al. Study on setup errors for
                                                                  different body carcinoma radiotherapy with image guidance
            11.  Ho D, Imai K, King G, Stuart EA. MatchIt: Nonparametric   in TOMO-HD. Chin J Radiol Health. 2021;30(3):331-338.
               preprocessing for parametric causal inference. J Stat Softw.
               2011;42(8):1-28.                                   doi: 10.13491/j.issn.1004-714x.2021.03.015
               doi: 10.18637/jss.v042.i08                      20.  Hui H, Wang Q, Cui L,  et al. Application of multimedia
                                                                  information technology on precision radiotherapy for
            12.  Zamboglou  N,  Achterrath  W,  Schnabel  T,  Lenaz  L,
               Kolotas  C, Schmitt G. Simultaneous radiotherapy and   patients with head and neck malignant tumors.  Chin J
               chemotherapy with carboplatin in inoperable squamous cell   Radiol Health. 2022;31(2):239-244.
               carcinoma of the head and neck: A phase II study. Cancer      doi: 10.13491/j.issn.1004-714X.2022.02.020











            Volume 2 Issue 1 (2024)                         6                       https://doi.org/10.36922/arnm.2519
   9   10   11   12   13   14   15   16   17   18   19